Diazepam attenuates the effects of cocaine on locomotion, 50‐kHz ultrasonic vocalizations and phasic dopamine in the nucleus accumbens of rats

Abstract

Background and Purpose: Currently, there is no effective drug to treat cocaine-use disorder, which affects millions of people worldwide. Benzodiazepines are potential therapeutic candidates, as microdialysis and voltammetry studies have shown that they can decrease dopamine concentrations in the nucleus accumbens of rodents and block the increase in dopamine levels and appetitive 50-kHz ultrasonic vocalizations (USVs) induced by amphetamine in rats.Experimental Approach: Here, we tested whether administration of 2.5-mgÁkg À1 diazepam (i.p.) in adult male rats could block the effects of 20-mgÁkg À1 cocaine (i.p.) on electrically evoked phasic dopamine signals in the nucleus accumbens measured by fast-scan cyclic voltammetry, as well as 50-kHz USV and locomotor activity.Key Results: Cocaine injection increased evoked dopamine signals up to threefold within 5 min, and the increase was significantly higher than baseline for at least 75 min. The injection of diazepam, 5 min after cocaine, attenuated the cocaine effect by nearly 50%, and this attenuation was maintained for at least 40 min. Behaviourally, cocaine increased the number of appetitive 50-kHz calls by about 12-fold. Diazepam significantly blocked this effect for the entire duration of the session. Also, cocainetreated rats were more active than controls and diazepam significantly attenuated cocaine-induced locomotion, by up to 50%. Conclusion and Implications:These results suggest that the neurochemical and psychostimulant effects of cocaine can be mitigated by diazepam.LINKED ARTICLES: This article is part of a themed issue on Building Bridges in Neuropharmacology. To view the other articles in this section visit http://onlinelibrary.

Identification of key genes and therapeutic drugs for cocaine addiction using integrated bioinformatics analysis

“…Recent research showed that CBD can be effective in reducing the reward and reinforcement effects of addictive drugs (Galaj et al, 2020 ). Among the drugs that affected the three genes, diazepam and melatonin might be useful therapeutic agents for reducing cocaine abuse (Takahashi et al, 2017 ; Barbosa-Méndez et al, 2021 ; Sanchez et al, 2022 ).…”

Effect of anlotinib combined with camrelizumab on clinical efficacy and short-term prognosis in male patients with advanced gastric cancer

“…The indole group of anlotinib has been found to effectively inhibit Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) and Vascular Endothelial Growth Factor Receptor 3 (VEGFR3), thereby preventing the formation of tumor vasculature and lymphatic vasculature and suppressing tumor metastasis [18,19]. Relevant clinical data [20,21] has indicated that the objective response rate and disease control rate of patients with advanced lung adenocarcinoma resistant to previous treatment could reach more than 40% and 80%, respectively, when treated with anlotinib.…”

Building Bridges In Neuropharmacology: New therapeutic approaches for psychiatric and neurodegenerative disorders

“…Despite the demand for the treatment of cocaine use disorder, the regulatory agencies for drug safety have not approved any pharmacological treatment for cocaine addiction (Sanchez et al, 2022). Most medications used were developed for other medical conditions.…”

“…Substance use disorders are conditions where effective pharmacotherapy is limited, risky or not available, and hence another area where effective pharmacotherapeutics are needed. There is evidence that intranasal oxytocin administration may be of benefit due to its anti-craving properties (Houghton et al, 2021published Despite the demand for the treatment of cocaine use disorder, the regulatory agencies for drug safety have not approved any pharmacological treatment for cocaine addiction (Sanchez et al, 2022).…”